LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager
暂无分享,去创建一个
S. Hipp | M. Bergmann | I. Tirapu | B. Thaler | L. Corrales | A. Vogt | K. Fuchs | Kathrin Bauer | N. Sabarth | Carina Binder | K. Martin | P. Adam | C. Walterskirchen | P. Chetta | M. Fabits | Barbara Thaler